68 related articles for article (PubMed ID: 15541036)
1. Expression of interleukin-22 in murine carcinoma cells did not influence tumour growth in vivo but did improve survival of the inoculated hosts.
Nagakawa H; Shimozato O; Yu L; Takiguchi Y; Tatsumi K; Kuriyama T; Tagawa M
Scand J Immunol; 2004 Nov; 60(5):449-54. PubMed ID: 15541036
[TBL] [Abstract][Full Text] [Related]
2. Expression of the interleukin-21 gene in murine colon carcinoma cells generates systemic immunity in the inoculated hosts.
Ugai S; Shimozato O; Kawamura K; Wang YQ; Yamaguchi T; Saisho H; Sakiyama S; Tagawa M
Cancer Gene Ther; 2003 Mar; 10(3):187-92. PubMed ID: 12637939
[TBL] [Abstract][Full Text] [Related]
3. Transduction of murine colon carcinoma cells with interleukin-15 gene induces antitumor effects in immunocompetent and immunocompromised hosts.
Tasaki K; Yoshida Y; Miyauchi M; Maeda T; Takenaga K; Kouzu T; Asano T; Ochiai T; Sakiyamna S; Tagawa M
Cancer Gene Ther; 2000 Feb; 7(2):255-61. PubMed ID: 10770634
[TBL] [Abstract][Full Text] [Related]
4. Secretion of interleukin-10 from murine colon carcinoma cells suppresses systemic antitumor immunity and impairs protective immunity induced against the tumors.
Kawamura K; Bahar R; Natsume W; Sakiyama S; Tagawa M
Cancer Gene Ther; 2002 Jan; 9(1):109-15. PubMed ID: 11916240
[TBL] [Abstract][Full Text] [Related]
5. Antitumor effects produced by transduction of dendritic cells-derived heterodimeric cytokine genes in murine colon carcinoma cells.
Chiyo M; Shimozato O; Iizasa T; Fujisawa T; Tagawa M
Anticancer Res; 2004; 24(6):3763-7. PubMed ID: 15736409
[TBL] [Abstract][Full Text] [Related]
6. Protective immunity is induced in murine colon carcinoma cells by the expression of interleukin-12 or interleukin-18, which activate type 1 helper T cells.
Tasaki K; Yoshida Y; Maeda T; Miyauchi M; Kawamura K; Takenaga K; Yamamoto H; Kouzu T; Asano T; Ochiai T; Sakiyama S; Tagawa M
Cancer Gene Ther; 2000 Feb; 7(2):247-54. PubMed ID: 10770633
[TBL] [Abstract][Full Text] [Related]
7. Temporal associations between interleukin 22 and the extracellular domains of IL-22R and IL-10R2.
Li J; Tomkinson KN; Tan XY; Wu P; Yan G; Spaulding V; Deng B; Annis-Freeman B; Heveron K; Zollner R; De Zutter G; Wright JF; Crawford TK; Liu W; Jacobs KA; Wolfman NM; Ling V; Pittman DD; Veldman GM; Fouser LA
Int Immunopharmacol; 2004 May; 4(5):693-708. PubMed ID: 15120653
[TBL] [Abstract][Full Text] [Related]
8. Antitumor activity and immune enhancement of murine interleukin-23 expressed in murine colon carcinoma cells.
Shan BE; Hao JS; Li QX; Tagawa M
Cell Mol Immunol; 2006 Feb; 3(1):47-52. PubMed ID: 16549049
[TBL] [Abstract][Full Text] [Related]
9. Blockade of the interleukin-21/interleukin-21 receptor pathway ameliorates disease in animal models of rheumatoid arthritis.
Young DA; Hegen M; Ma HL; Whitters MJ; Albert LM; Lowe L; Senices M; Wu PW; Sibley B; Leathurby Y; Brown TP; Nickerson-Nutter C; Keith JC; Collins M
Arthritis Rheum; 2007 Apr; 56(4):1152-63. PubMed ID: 17393408
[TBL] [Abstract][Full Text] [Related]
10. IL-23 promotes tumour incidence and growth.
Langowski JL; Zhang X; Wu L; Mattson JD; Chen T; Smith K; Basham B; McClanahan T; Kastelein RA; Oft M
Nature; 2006 Jul; 442(7101):461-5. PubMed ID: 16688182
[TBL] [Abstract][Full Text] [Related]
11. Neutralization of interleukin-2 retards the growth of mouse renal cancer.
Fukuhara H; Matsumoto A; Kitamura T; Takeuchi T
BJU Int; 2006 Jun; 97(6):1314-21. PubMed ID: 16686731
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-21 triggers both cellular and humoral immune responses leading to therapeutic antitumor effects against head and neck squamous cell carcinoma.
Nakano H; Kishida T; Asada H; Shin-Ya M; Shinomiya T; Imanishi J; Shimada T; Nakai S; Takeuchi M; Hisa Y; Mazda O
J Gene Med; 2006 Jan; 8(1):90-9. PubMed ID: 16097036
[TBL] [Abstract][Full Text] [Related]
13. Is there an interaction between interleukin-10 and interleukin-22?
Wolk K; Witte E; Reineke U; Witte K; Friedrich M; Sterry W; Asadullah K; Volk HD; Sabat R
Genes Immun; 2005 Feb; 6(1):8-18. PubMed ID: 15526001
[TBL] [Abstract][Full Text] [Related]
14. Murine NKT cells produce Th17 cytokine interleukin-22.
Goto M; Murakawa M; Kadoshima-Yamaoka K; Tanaka Y; Nagahira K; Fukuda Y; Nishimura T
Cell Immunol; 2009; 254(2):81-4. PubMed ID: 19010461
[TBL] [Abstract][Full Text] [Related]
15. Induction of systemic immunity by expression of interleukin-23 in murine colon carcinoma cells.
Wang YQ; Ugai S; Shimozato O; Yu L; Kawamura K; Yamamoto H; Yamaguchi T; Saisho H; Tagawa M
Int J Cancer; 2003 Jul; 105(6):820-4. PubMed ID: 12767068
[TBL] [Abstract][Full Text] [Related]
16. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy.
Chen HW; Liao CH; Ying C; Chang CJ; Lin CM
Clin Immunol; 2006 Apr; 119(1):21-31. PubMed ID: 16406844
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-12-responding asialoGM1+CD8+ central memory-type T cells as precursor cells for interferon-gamma-producing killer T cells.
Kosaka A; Lee U; Wakita D; Matsubara N; Togashi Y; Nishimura S; Kitamura H; Nishimura T
Cancer Sci; 2006 Nov; 97(11):1236-41. PubMed ID: 16952305
[TBL] [Abstract][Full Text] [Related]
18. Melanoma differentiation-associated gene-7 (mda-7)/interleukin (IL)-24 induces anticancer immunity in a syngeneic murine model.
Miyahara R; Banerjee S; Kawano K; Efferson C; Tsuda N; Miyahara Y; Ioannides CG; Chada S; Ramesh R
Cancer Gene Ther; 2006 Aug; 13(8):753-61. PubMed ID: 16543916
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-21 activates cytotoxic T lymphocytes and natural killer cells to generate antitumor response in mouse renal cell carcinoma.
Kumano M; Hara I; Furukawa J; Oniki S; Nagai H; Miyake H; Fujisawa M
J Urol; 2007 Oct; 178(4 Pt 1):1504-9. PubMed ID: 17707061
[TBL] [Abstract][Full Text] [Related]
20. Factors effecting the Th2-like immune response after gamma-irradiation: low production of IL-12 heterodimer in antigen-presenting cells and small expression of the IL-12 receptor in T cells.
Park HR; Jo SK; Paik SG
Int J Radiat Biol; 2005 Mar; 81(3):221-31. PubMed ID: 16019931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
